Gold bars to be exempt from tariffs, White House clarifies
Celsius Holdings , Inc. (NASDAQ:CELH), a $9 billion market cap company specializing in the production of bottled and canned soft drinks, announced significant changes following its recent Annual Meeting of Stockholders. According to InvestingPro data, the company maintains a "GREAT" financial health score and holds more cash than debt on its balance sheet. The company, incorporated in Nevada, has approved the implementation of two new stock plans and an increase in the number of authorized shares of common stock.
During the Annual Meeting held on May 28, 2025, stockholders voted in favor of the Celsius Holdings, Inc. 2025 Omnibus Incentive Compensation Plan, which allows for the issuance of up to 6,000,000 shares of common stock, and the Celsius Holdings, Inc. 2025 Employee Stock Purchase Plan, with up to 850,000 shares of common stock available for issuance.
Additionally, an amendment to the company’s Articles of Incorporation was approved to increase the authorized common stock from 300,000,000 to 400,000,000 shares. This amendment was filed and became effective on May 28, 2025, as recorded with the Secretary of State of Nevada.
The Annual Meeting also included the election of nine directors to serve until the 2026 annual meeting, the approval of a non-binding advisory resolution on executive compensation, and the ratification of Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2025.
The implementation of the new stock plans and the increase in authorized shares are part of Celsius Holdings’ broader strategy to incentivize and retain talent through stock-based compensation. These changes are detailed in the company’s latest 8-K filing with the Securities and Exchange Commission.
In other recent news, Celsius Holdings reported its first-quarter 2025 earnings, which fell short of analyst expectations. The company posted an earnings per share (EPS) of $0.18, missing the forecasted $0.20, and recorded revenue of $329.3 million, below the anticipated $348.62 million. Despite the earnings miss, Celsius noted a 41% increase in international revenue and a gross margin expansion of 110 basis points to 52.3%. TD Cowen responded by raising Celsius’s stock price target to $37.00, maintaining a Hold rating, while BofA Securities kept its Underperform rating with a $30.00 target. The integration of Alani Nu into Celsius’s portfolio is a focus for future growth, with analysts awaiting more details on its financial impact. BofA Securities highlighted complexities in assessing Celsius’s performance due to promotional dynamics and distribution changes. Both firms noted the importance of the upcoming call where Celsius management will discuss the strategic implications of the Alani Nu acquisition.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.